Does RITUXIMAB Cause Diffuse large b-cell lymphoma recurrent? 1,359 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,359 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with RITUXIMAB (Rituxan). This represents 0.8% of all adverse event reports for RITUXIMAB.
1,359
Reports of Diffuse large b-cell lymphoma recurrent with RITUXIMAB
0.8%
of all RITUXIMAB reports
171
Deaths
203
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From RITUXIMAB?
Of the 1,359 reports, 171 (12.6%) resulted in death, 203 (14.9%) required hospitalization, and 94 (6.9%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 1,359 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
BENDAMUSTINE (255)
Which RITUXIMAB Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE